PT-141
PT-141 (Bremelanotide) 10mg is a central-acting peptide affecting the melanocortin pathway, including MC receptors. It has been studied in preclinical models for potential effects on central signaling processes, response behavior, and neuroendocrine regulation.
- The description claims PT-141 has been studied for potential effects on central signaling processes, response behavior, and neuroendocrine regulation.
AI Readiness
Good foundation, but some important product data is still missing.
61%